Sand Grove Capital Management
Latest statistics and disclosures from Sand Grove Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are TXNM, WBD, EA, HOLX, NSC, and represent 49.36% of Sand Grove Capital Management's stock portfolio.
- Added to shares of these 10 stocks: WBD (+$29M), HOLX (+$28M), RNA (+$24M), DVAX (+$24M), FOLD (+$24M), EXAS (+$23M), KVUE (+$22M), CDTX (+$18M), AXTA (+$16M), EA (+$5.8M).
- Started 9 new stock positions in RNA, EXAS, KVUE, WBD, HOLX, FOLD, DVAX, CDTX, AXTA.
- Reduced shares in these 9 stocks: K (-$27M), MRUS (-$23M), STAA (-$22M), CYBR (-$19M), OMC (-$15M), ALE (-$11M), SRDX, CCRN, RKT.
- Sold out of its positions in ALE, CCRN, K, OMC, RKT, STAA, SRDX, CYBR, MRUS.
- Sand Grove Capital Management was a net buyer of stock by $90M.
- Sand Grove Capital Management has $295M in assets under management (AUM), dropping by 44.12%.
- Central Index Key (CIK): 0001665077
Tip: Access up to 7 years of quarterly data
Positions held by Sand Grove Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sand Grove Capital Management
Sand Grove Capital Management holds 12 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| PNM Resources (TXNM) | 11.9 | $35M | 597k | 58.88 |
|
|
| Warner Bros Discovery Com Ser A (WBD) | 9.9 | $29M | NEW | 1.0M | 28.82 |
|
| Electronic Arts (EA) | 9.7 | $29M | +25% | 140k | 204.33 |
|
| Hologic (HOLX) | 9.5 | $28M | NEW | 378k | 74.49 |
|
| Norfolk Southern (NSC) | 8.3 | $25M | 85k | 288.72 |
|
|
| Avidity Biosciences Ord (RNA) | 8.1 | $24M | NEW | 332k | 72.13 |
|
| Dynavax Technologies Corp Com New (DVAX) | 8.0 | $24M | NEW | 1.5M | 15.38 |
|
| Amicus Therapeutics (FOLD) | 8.0 | $24M | NEW | 1.6M | 14.24 |
|
| EXACT Sciences Corporation (EXAS) | 7.9 | $23M | NEW | 229k | 101.56 |
|
| Kenvue (KVUE) | 7.4 | $22M | NEW | 1.3M | 17.25 |
|
| Cidara Therapeutics Com New (CDTX) | 6.1 | $18M | NEW | 81k | 220.89 |
|
| Axalta Coating Sys (AXTA) | 5.2 | $16M | NEW | 479k | 32.31 |
|
Past Filings by Sand Grove Capital Management
SEC 13F filings are viewable for Sand Grove Capital Management going back to 2015
- Sand Grove Capital Management 2025 Q4 filed Feb. 17, 2026
- Sand Grove Capital Management 2025 Q3 filed Nov. 14, 2025
- Sand Grove Capital Management 2025 Q2 filed Aug. 14, 2025
- Sand Grove Capital Management 2025 Q1 filed May 15, 2025
- Sand Grove Capital Management 2024 Q4 filed Feb. 14, 2025
- Sand Grove Capital Management 2024 Q3 filed Nov. 14, 2024
- Sand Grove Capital Management 2024 Q2 filed Aug. 14, 2024
- Sand Grove Capital Management 2024 Q1 filed May 14, 2024
- Sand Grove Capital Management 2023 Q4 filed Feb. 14, 2024
- Sand Grove Capital Management 2023 Q3 filed Nov. 14, 2023
- Sand Grove Capital Management 2023 Q2 filed Aug. 11, 2023
- Sand Grove Capital Management 2023 Q1 filed May 15, 2023
- Sand Grove Capital Management 2022 Q4 filed Feb. 14, 2023
- Sand Grove Capital Management 2022 Q3 filed Nov. 14, 2022
- Sand Grove Capital Management 2022 Q2 filed Aug. 15, 2022
- Sand Grove Capital Management 2022 Q1 filed May 16, 2022